Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna (NASDAQ:MRNA) has announced it will host a live conference call and webcast on Friday, February 14, 2025, at 8:00 a.m. ET to present its fourth quarter and full year 2024 financial results, along with a corporate update. The webcast will be available in the "Events and Presentations" section of Moderna's investor website. Following the conference call, an archived version of the webcast will be accessible on the company's website for one year.
Moderna (NASDAQ:MRNA) ha annunciato che ospiterà una conferenza telefonica dal vivo e una webstreaming venerdì 14 febbraio 2025, alle 8:00 ET per presentare i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024, insieme a un aggiornamento aziendale. Il webcast sarà disponibile nella sezione "Eventi e Presentazioni" del sito web per gli investitori di Moderna. Dopo la conferenza telefonica, una versione archiviata del webcast sarà accessibile sul sito web dell'azienda per un anno.
Moderna (NASDAQ:MRNA) ha anunciado que realizará una conferencia telefónica en vivo y una transmisión web el viernes 14 de febrero de 2025, a las 8:00 a.m. ET para presentar sus resultados financieros del cuarto trimestre y del año completo 2024, junto con una actualización corporativa. La transmisión web estará disponible en la sección "Eventos y Presentaciones" del sitio web para inversionistas de Moderna. Después de la conferencia telefónica, una versión archivada de la transmisión estará accesible en el sitio web de la compañía durante un año.
모더나(NASDAQ:MRNA)는 2025년 2월 14일 금요일, 동부 표준시 기준 오전 8시에 2024년 4분기 및 연간 재무 결과를 발표하고 기업 업데이트를 제공하는 라이브 컨퍼런스 콜 및 웹 캐스트를 개최한다고 발표했습니다. 웹 캐스트는 모더나 투자자 웹사이트의 "이벤트 및 프레젠테이션" 섹션에서 이용할 수 있습니다. 컨퍼런스 콜 후, 웹 캐스트의 아카이브 버전은 회사 웹사이트에서 1년 동안 접근할 수 있습니다.
Moderna (NASDAQ:MRNA) a annoncé qu'elle organisera une conférence téléphonique en direct et un webinaire le vendredi 14 février 2025, à 8h00 ET pour présenter ses résultats financiers du quatrième trimestre et de l'année 2024, ainsi qu'une mise à jour de l'entreprise. Le webinaire sera disponible dans la section "Événements et Présentations" du site Web des investisseurs de Moderna. Après la conférence téléphonique, une version archivée du webinaire sera accessible sur le site de l'entreprise pendant un an.
Moderna (NASDAQ:MRNA) hat angekündigt, dass am Freitag, den 14. Februar 2025, um 8:00 Uhr ET eine Live-Konferenzschaltung und Webcast stattfinden wird, um die Finanzberichte für das vierte Quartal und das Gesamtjahr 2024 sowie ein Unternehmensupdate zu präsentieren. Der Webcast wird im Bereich "Veranstaltungen und Präsentationen" der Investorenseite von Moderna verfügbar sein. Nach der Konferenzschaltung wird eine archivierte Version des Webcasts für ein Jahr auf der Website des Unternehmens zugänglich sein.
- None.
- None.
CAMBRIDGE, MA / ACCESS Newswire / January 29, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 14, 2025 to report its fourth quarter and full year 2024 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Moderna (MRNA) report Q4 and full year 2024 earnings?
How can investors access Moderna's (MRNA) Q4 2024 earnings call?
How long will Moderna's (MRNA) Q4 2024 earnings webcast be available?
What information will be covered in Moderna's (MRNA) February 14, 2025 presentation?
